Skip to main content

Articles

Page 30 of 32

  1. Genomic data often persist far beyond the initial study in which they were generated. But the true value of the data is tied to their being both used and useful, and the usefulness of the data relies intimatel...

    Authors: John Quackenbush
    Citation: Genome Medicine 2009 1:111
  2. Although the literature concerning statistical testing for genotype-phenotype association in family-based and population-based studies is very extensive, until recently the sex chromosomes have received little...

    Authors: David G Clayton
    Citation: Genome Medicine 2009 1:110
  3. A function for the microRNA (miRNA) pathway in vascular development and angiogenesis has been firmly established. miRNAs with selective expression in the vasculature are attractive as possible targets in miRNA...

    Authors: Erik Larsson, Peder Fredlund Fuchs, Johan Heldin, Irmeli Barkefors, Cecilia Bondjers, Guillem Genové, Christelle Arrondel, Pär Gerwins, Christine Kurschat, Bernhard Schermer, Thomas Benzing, Scott J Harvey, Johan Kreuger and Per Lindahl
    Citation: Genome Medicine 2009 1:108
  4. The inflammatory bowel diseases, Crohn's disease and ulcerative colitis, pose a fascinating challenge to specialists in gastroenterology, infectious diseases, immunology and genetics and an often crushing burd...

    Authors: David G Nathan and Stuart H Orkin
    Citation: Genome Medicine 2009 1:103
  5. Technological advances have enabled a better characterization of all the genetic alterations in tumors. A picture that emerges is that tumor cells are much more genetically heterogeneous than originally expect...

    Authors: Sandro J de Souza, Beatriz Stransky and Anamaria A Camargo
    Citation: Genome Medicine 2009 1:101
  6. Genome-wide association studies are the most comprehensive and straightforward approach to teasing out the identity of genetic polymorphisms associated with any given disease or characteristic. With the availa...

    Authors: Bruce N Cronstein
    Citation: Genome Medicine 2009 1:98
  7. Transposable elements (TEs) have been consistently underestimated in their contribution to genetic instability and human disease. TEs can cause human disease by creating insertional mutations in genes, and als...

    Authors: Victoria P Belancio, Prescott L Deininger and Astrid M Roy-Engel
    Citation: Genome Medicine 2009 1:97
  8. Mitochondrial disorders can originate from mutations in one of many nuclear genes controlling the organelle function or in the mitochondrial genome (mitochondrial DNA (mtDNA)). The large numbers of potential c...

    Authors: Valeria Vasta, Sarah B Ng, Emily H Turner, Jay Shendure and Si Houn Hahn
    Citation: Genome Medicine 2009 1:100
  9. In June 2009, the Science and Technology Committee of the UK House of Lords published a report on genomic medicine, based on expert evidence collected over an 18-month period. Crucially, the report signaled th...

    Authors: Hilary Burton, Caroline F Wright and Ron Zimmern
    Citation: Genome Medicine 2009 1:93
  10. Systems biology has matured considerably as a discipline over the last decade, yet some of the key challenges separating current research efforts in systems biology and clinically useful results are only now b...

    Authors: Gilles Clermont, Charles Auffray, Yves Moreau, David M Rocke, Daniel Dalevi, Devdatt Dubhashi, Dana R Marshall, Peter Raasch, Frank Dehne, Paolo Provero, Jesper Tegner, Bruce J Aronow, Michael A Langston and Mikael Benson
    Citation: Genome Medicine 2009 1:88
  11. Translation of research findings into clinical practice is an important aspect of medical progress. Even for the early stages of genomics, research aiming to deepen understandings of underlying mechanisms of d...

    Authors: Naomi Hawkins, Jantina de Vries, Paula Boddington, Jane Kaye and Catherine Heeney
    Citation: Genome Medicine 2009 1:87
  12. Gene patents have generally not impeded biomedical research, but some problems that arise in genetic diagnostics can be attributed to exclusively licensed gene patents. Gene patents for therapeutics have often...

    Authors: Subhashini Chandrasekharan and Robert Cook-Deegan
    Citation: Genome Medicine 2009 1:92
  13. A major transition in human population structure is currently under way, moving from a historical metapopulation, comprising small and mainly rural endogamous communities, to large and increasingly panmictic u...

    Authors: Harry Campbell, Igor Rudan, Alan H Bittles and Alan F Wright
    Citation: Genome Medicine 2009 1:91
  14. Recent studies have demonstrated that network approaches are highly appropriate tools for understanding the extreme complexity of the aging process. Moreover, the generality of the network concept helps to def...

    Authors: Gábor I Simkó, Dávid Gyurkó, Dániel V Veres, Tibor Nánási and Peter Csermely
    Citation: Genome Medicine 2009 1:90
  15. From the point of view of genome medicine, Barack Obama has made two vital policy decisions: he has chosen a new director of the National Institutes of Health, and his proposed change in United States healthca...

    Authors: David G Nathan and Stuart H Orkin
    Citation: Genome Medicine 2009 1:86
  16. The need for an integrated view of data obtained from high-throughput technologies gave rise to network analyses. These are especially useful to rationalize how external perturbations propagate through the exp...

    Authors: Elisabet Selga, Carlota Oleaga, Sara Ramírez, M Cristina de Almagro, Véronique Noé and Carlos J Ciudad
    Citation: Genome Medicine 2009 1:83
  17. Granulosa cell tumors (GCTs) of the ovary belong to the group of ovarian sex-cord stromal tumors and represent 5 to 10% of ovarian malignancies. GCTs exhibit several morphological, biochemical and hormonal fea...

    Authors: Nicolas Kalfa, Reiner A Veitia, Bérénice A Benayoun, Brigitte Boizet-Bonhoure and Charles Sultan
    Citation: Genome Medicine 2009 1:81
  18. For almost three decades, Huntington's disease has been a prototype for the application of genetic strategies to human disease. HD, the Huntington's disease gene, was the first autosomal defect mapped using only ...

    Authors: James F Gusella and Marcy E MacDonald
    Citation: Genome Medicine 2009 1:80
  19. Since the 1950s, lithium salts have been the main line of treatment for bipolar disorder (BD), both as a prophylactic and as an episodic treatment agent. Like many psychiatric conditions, BD is genetically and...

    Authors: Cristiana Cruceanu, Martin Alda and Gustavo Turecki
    Citation: Genome Medicine 2009 1:79
  20. Genome-wide association analyses on large patient cohorts are generating large sets of candidate disease genes. This is coupled with the availability of ever-increasing genomic databases and a rapidly expandin...

    Authors: Nicki Tiffin, Miguel A Andrade-Navarro and Carolina Perez-Iratxeta
    Citation: Genome Medicine 2009 1:77
  21. The age at natural menopause shows great variability. It has been proposed that early age at menopause is a risk factor for osteoporosis and cardiovascular disease, whereas later age at menopause is a risk fac...

    Authors: Francisco Jesus Moron, Agustin Ruiz and Jose Jorge Galan
    Citation: Genome Medicine 2009 1:76
  22. Will the routine availability of genome sequence information on individuals render family history information obsolete? I argue that it will not, both because the taking of a family history has other uses for ...

    Authors: Angus John Clarke
    Citation: Genome Medicine 2009 1:75
  23. Neuroblastoma is one of the most common solid tumors of childhood, arising from immature sympathetic nervous system cells. The clinical course of patients with neuroblastoma is highly variable, ranging from sp...

    Authors: Nadine Van Roy, Katleen De Preter, Jasmien Hoebeeck, Tom Van Maerken, Filip Pattyn, Pieter Mestdagh, Joëlle Vermeulen, Jo Vandesompele and Frank Speleman
    Citation: Genome Medicine 2009 1:74
  24. Psoriasis is recognized as a complex disease for which multiple genetic and non-genetic factors influence susceptibility. The major susceptibility locus resides in the MHC class I region and, until relatively ...

    Authors: Rhodri Ll Smith, Richard B Warren, Christopher EM Griffiths and Jane Worthington
    Citation: Genome Medicine 2009 1:72
  25. Medical treatment for patients has historically been based on two primary elements: the expected outcome for the patient, and the ability of treatment to improve the expected outcome. The advance in genomic te...

    Authors: Sumithra J Mandrekar and Daniel J Sargent
    Citation: Genome Medicine 2009 1:69
  26. The incidence of cancer and its associated mortality are increasing globally, indicating an urgent need to develop even more effective and sensitive sets of biomarkers that could help in early diagnosis and co...

    Authors: Mohamed SS Alhamdani, Christoph Schröder and Jörg D Hoheisel
    Citation: Genome Medicine 2009 1:68
  27. Prion diseases share common features of neurodegenerative disorders, infectious diseases and pathologies linked to misfolded proteins. Whether these aspects are independently and fortuitously present in prion ...

    Authors: Maurizio Pocchiari, Anna Poleggi, Serena Principe, Silvia Graziano and Franco Cardone
    Citation: Genome Medicine 2009 1:63
  28. DNA copy number variations (CNVs) are an important component of genetic variation, affecting a greater fraction of the genome than single nucleotide polymorphisms (SNPs). The advent of high-resolution SNP arra...

    Authors: Adam Shlien and David Malkin
    Citation: Genome Medicine 2009 1:62
  • Editorial Board
  • Editorial Team
  • Call for EBMs
  • Sign up for article alerts and news from this journal
  • Contact us
  • Announcements

    C19 Rapid Review initiative

    Genome Medicine has joined the C19 Rapid Review initiative, a cross-publisher collaboration to ensure that COVID-19 research is reviewed and published as quickly and openly as possible. Learn more here

    Submissions from medRxiv 

    Authors are now able to submit manuscripts to Genome Medicine directly from medRxiv without having to re-upload files.

    Portable peer review

    To reduce time spent on serial submissions and iterative reviewing, Genome Medicine offers to consider manuscripts on the basis of reviews received at other journals. We also support transfers of reviews obtained at Genome Medicine to other journals, including those outside of BMC and Springer Nature. Learn more from our peer review policy page.

    COVID-19 submissions

    In response to the current SARS-CoV-2 pandemic Genome Medicine editors will treat relevant submissions with high priority.

Annual Journal Metrics